bioAffinity Technologies, Inc. (BIAF)
6.055
-0.09
(-1.46%)
USD |
NASDAQ |
Oct 02, 16:00
6.06
0.00 (0.00%)
Pre-Market: 20:00
bioAffinity Technologies Net Income (Quarterly) : -3.366M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.366M |
| March 31, 2026 | -3.631M |
| December 31, 2025 | -3.138M |
| September 30, 2025 | -5.051M |
| June 30, 2025 | -4.061M |
| March 31, 2025 | -2.660M |
| December 31, 2024 | -2.967M |
| September 30, 2024 | -2.001M |
| June 30, 2024 | -2.110M |
| March 31, 2024 | -1.962M |
| December 31, 2023 | -2.373M |
| September 30, 2023 | -2.291M |
| Date | Value |
|---|---|
| June 30, 2023 | -1.740M |
| March 31, 2023 | -1.533M |
| December 31, 2022 | -1.675M |
| September 30, 2022 | -4.920M |
| June 30, 2022 | -0.0881M |
| March 31, 2022 | -1.472M |
| December 31, 2021 | -5.577M |
| September 30, 2021 | -1.514M |
| June 30, 2021 | 1.480M |
| March 31, 2021 | -0.7162M |
| December 31, 2020 | -2.136M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Veracyte, Inc. | 25.49M |
| Quantum Cyber NV | -2.486M |
| MediciNova, Inc. | -2.314M |
| ADMA Biologics, Inc. | 37.82M |
| ACADIA Pharmaceuticals, Inc. | 31.50M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.511M |
| Total Expenses (Quarterly) | 4.877M |
| EPS Diluted (Quarterly) | -9.660 |
| Enterprise Value | 1.743M |
| Gross Profit Margin (Quarterly) | 23.91% |
| Profit Margin (Quarterly) | -222.8% |
| Earnings Yield | -1.71K% |
| Normalized Earnings Yield | -1259.06 |